Navigation Links
EMBL scientists develop first fully automated pipeline for multiprotein complex production
Date:5/4/2009

Most cellular processes are carried out by molecular machines that consist of many interacting proteins. These protein complexes lie at the heart of life science research, but they are notoriously hard to study. Their abundance is often too low to extract them directly from cells and generating them with recombinant methods has been a daunting task. A new technology to produce multiprotein complexes, developed by researchers at the European Molecular Biology Laboratory (EMBL) in Grenoble, France, and the Paul Scherrer Institute (PSI) in Villigen, Switzerland, now makes the biologist's life easier.

In a paper published in the current issue of Nature Methods researchers of the groups of Imre Berger at EMBL and Michel Steinmetz at the PSI describe ACEMBL, the first fully automated pipeline for the production of multiprotein complexes. Requiring much less effort and materials, the new pipeline will speed up structural studies of protein complexes and will allow to decipher as yet elusive molecular mechanisms of health and disease.

ACEMBL can produce complexes consisting of different types of components, including protein, RNA and other biomolecules. Currently designed to express proteins in the standard system Escherichium coli, the automated pipeline will in future be adapted for complex production in eukaryotic cells. This will allow the study of even larger, more complicated complexes of human origin, including many promising drug targets. The system has already attracted commercial interest.


'/>"/>

Contact: Anna-Lynn Wegener
wegener@embl.de
49-622-138-7452
European Molecular Biology Laboratory
Source:Eurekalert

Page: 1

Related biology news :

1. Neuroscientists discover long-term potentiation in the olfactory bulb
2. March of Dimes awards $250,000 prize to scientists unraveling the causes of muscular dystrophy
3. Scientists shed light on inner workings of human embryonic stem cells
4. Stanford scientists turn adult skin cells into muscle and vice versa
5. Just in time for spring: Scientists find the cellular on and off switch for allergies and asthma
6. Geoscientists meet to discuss Rocky Mountain geology
7. Gladstone scientists identify key factors in heart cell creation
8. Fire is important part of global climate change, report scientists
9. Scientists give a hand(edness) to the search for alien life
10. Caltech scientists show why anti-HIV antibodies are ineffective at blocking infection
11. Marine scientists warn of potential for spring, summer red tide outbreak in Gulf of Maine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)...  RSA Conference -- RSA, a Dell Technologies business, ... enhance fraud detection and investigation across digital environments ... & Risk Intelligence Suite. The new platform is ... from internal and external sources as well as ... from targeted cybercrime attacks. "Fraudsters are ...
(Date:2/10/2017)... -- Research and Markets has announced the ... Scientific and Commercial Aspects" to their offering. ... Biomarkers play ... therapy for selection of treatment as well for monitoring the ... disease in modern medicine. Biochip/microarray technologies and next generation sequencing ...
(Date:2/8/2017)... NEW YORK , Feb. 8, 2017 /PRNewswire/ ... an individual,s voice to match it against a ... voice such as pitch, cadence, and tone are ... systems require minimal hardware installation, as most PCs ... remotely for different transactions. Voice recognition biometrics are ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... PARK, Calif. and GREENWICH, ... Capital, a private investment firm focused on venture ... announced the promotion of Josh Richardson , ... focuses on investments in biotechnology companies.  He is ... has played important roles in Longitude,s investments in ...
(Date:2/16/2017)...   Capricor Therapeutics, Inc. (NASDAQ: ... first-in-class biological therapies for cardiac and other medical ... terminate its license agreement with the Mayo Clinic ... "Our decision to return these rights ... efforts to advance our core cell and exosome-based ...
(Date:2/16/2017)... DIEGO , Feb. 16, 2017  Dermata ... innovative products to treat a variety of dermatological ... million Series 1a financing and entered into a ... (SVB).  Dermata intends to use the capital for ... making major advancements in the treatment of serious ...
(Date:2/16/2017)... 2017  Rhythm, a biopharmaceutical company developing ... result in life-threatening metabolic disorders, today announced ... round of financing with existing investors including ... Enterprise Associates, Pfizer Venture Investments, Third Rock ... fund. Rhythm will use the proceeds to ...
Breaking Biology Technology: